SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Manning Patrick)
 

Sökning: WFRF:(Manning Patrick) > (2020-2023) > Loss of RREB1 in pa...

Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression

Mattis, Katia K (författare)
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Krentz, Nicole A J (författare)
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Metzendorf, Christoph (författare)
Uppsala universitet,Institutionen för immunologi, genetik och patologi,Science for Life Laboratory, SciLifeLab
visa fler...
Abaitua, Fernando (författare)
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Spigelman, Aliya F (författare)
Department of Pharmacology, University of Alberta, Edmonton, AB, Canada.
Sun, Han (författare)
Division of Endocrinology, Department of Pediatrics, Stanford School of Medicine, Stanford University, Stanford, CA, USA.
Ikle, Jennifer M (författare)
Division of Endocrinology, Department of Pediatrics, Stanford School of Medicine, Stanford University, Stanford, CA, USA.
Thaman, Swaraj (författare)
Division of Endocrinology, Department of Pediatrics, Stanford School of Medicine, Stanford University, Stanford, CA, USA.
Rottner, Antje K (författare)
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Bautista, Austin (författare)
Department of Pharmacology, University of Alberta, Edmonton, AB, Canada.
Mazzaferro, Eugenia (författare)
Uppsala universitet,Institutionen för immunologi, genetik och patologi,Science for Life Laboratory, SciLifeLab
Perez-Alcantara, Marta (författare)
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Manning Fox, Jocelyn E (författare)
Department of Pharmacology, University of Alberta, Edmonton, AB, Canada.
Torres, Jason M (författare)
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Wesolowska-Andersen, Agata (författare)
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Yu, Grace Z (författare)
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Mahajan, Anubha (författare)
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Larsson, Anders (författare)
Uppsala universitet,Klinisk kemi
MacDonald, Patrick E (författare)
Department of Pharmacology, University of Alberta, Edmonton, AB, Canada.
Davies, Benjamin (författare)
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
den Hoed, Marcel, 1980- (författare)
Uppsala universitet,Institutionen för immunologi, genetik och patologi,Science for Life Laboratory, SciLifeLab
Gloyn, Anna L (författare)
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
visa färre...
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK. (creator_code:org_t)
2023-01-12
2023
Engelska.
Ingår i: Diabetologia. - : Springer Nature. - 0012-186X .- 1432-0428. ; 66:4, s. 674-694
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • AIMS/HYPOTHESIS: Genome-wide studies have uncovered multiple independent signals at the RREB1 locus associated with altered type 2 diabetes risk and related glycaemic traits. However, little is known about the function of the zinc finger transcription factor Ras-responsive element binding protein 1 (RREB1) in glucose homeostasis or how changes in its expression and/or function influence diabetes risk.METHODS: A zebrafish model lacking rreb1a and rreb1b was used to study the effect of RREB1 loss in vivo. Using transcriptomic and cellular phenotyping of a human beta cell model (EndoC-βH1) and human induced pluripotent stem cell (hiPSC)-derived beta-like cells, we investigated how loss of RREB1 expression and activity affects pancreatic endocrine cell development and function. Ex vivo measurements of human islet function were performed in donor islets from carriers of RREB1 type 2 diabetes risk alleles.RESULTS: CRISPR/Cas9-mediated loss of rreb1a and rreb1b function in zebrafish supports an in vivo role for the transcription factor in beta cell mass, beta cell insulin expression and glucose levels. Loss of RREB1 also reduced insulin gene expression and cellular insulin content in EndoC-βH1 cells and impaired insulin secretion under prolonged stimulation. Transcriptomic analysis of RREB1 knockdown and knockout EndoC-βH1 cells supports RREB1 as a novel regulator of genes involved in insulin secretion. In vitro differentiation of RREB1KO/KO hiPSCs revealed dysregulation of pro-endocrine cell genes, including RFX family members, suggesting that RREB1 also regulates genes involved in endocrine cell development. Human donor islets from carriers of type 2 diabetes risk alleles in RREB1 have altered glucose-stimulated insulin secretion ex vivo, consistent with a role for RREB1 in regulating islet cell function.CONCLUSIONS/INTERPRETATION: Together, our results indicate that RREB1 regulates beta cell function by transcriptionally regulating the expression of genes involved in beta cell development and function.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Nyckelord

Beta cell
CRISPR/Cas9
Diabetes
Differentiation
Human genetics
Pancreatic islet
RREB1
Stem cell
Transcription factor
Zebrafish

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy